Results 21 to 30 of about 848 (166)

Atypical scleromyxedema presenting with cutaneous and cardiovascular manifestations [PDF]

International Medical Case Reports Journal, 2016
Sue-Ann Teh,1 David A Kandiah2 1Department of Health Western Australia, Bunbury Hospital, Bunbury, 2School of Psychiatry and Clinical Neurosciences, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, WA ...
Teh SA, Kandiah DA
doaj   +1 more source

Scleromyxedema as a manifestation of monoclonal gammopathy of clinical significance

Vestnik Dermatologii i Venerologii
The article describes a 57-year-old female patient with lesions on the scalp, trunk and extremities, who was diagnosed with scleromyxedema (myxedematous lichen) by a dermatovenereologist based on clinical data and histopathological examination of a skin ...
Vadim V. Chikin, Maiia V. Soloveva, Alla M. Kovrigina, Maria A. Nefedova   +3 more
doaj   +2 more sources

Scleromyxedema Treated Successfully with Methotrexate

Journal of Clinical Rheumatology and Immunology
Background: Scleromyxedema is a rare, chronic cutaneous mucinosis of unknown etiology, characterized by widespread papular eruptions, dermal mucin deposition, fibroblast proliferation, and frequent systemic involvement.
Ravinash Ratnam, Jasmin Raja
doaj   +2 more sources

Unusual Cutaneous Manifestations in a Patient with a History of Hepatitis B: A Case of Scleromyxedema and Literature Review [PDF]

Clinical, Cosmetic and Investigational Dermatology
Aili Gao, Xin Tian, Dexiu Lang, Yue Chen Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Yue Chen, Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, People’s ...
Gao A, Tian X, Lang D, Chen Y
doaj   +2 more sources

Scleromyxedema [PDF]

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020
SummaryScleromyxedema is a rare, cutaneous deposition disorder from the group of mucinoses, which can affect multiple organs and is virtually always associated with a monoclonal gammopathy. Cutaneous manifestations are usually generalized, 2 to 3 mm sized, dome‐shaped or flat‐topped, waxy, slightly red to skin‐colored papules and sclerodermoid ...
Jochen H O, Hoffmann, Alexander H, Enk
openaire   +4 more sources

Scleredema Associated With IgG/κ Monoclonal Gammopathy of Clinical Significance Successfully Treated With Daratumumab Monotherapy: A Case Report. [PDF]

EJHaem
ABSTRACT Background Cutaneous monoclonal gammopathy of clinical significance (MGCS) is rare and may present with scleredema‐like fibrosing skin disease. Case A 59‐year‐old man developed progressive induration of the upper body. Laboratory studies revealed an IgG/κ monoclonal protein, and skin biopsy showed dermal thickening with mucin deposition.
Marcolongo D, Bressan A, Zanatta E, Alaibac MSA, Gianesello I, Binotto G, Pavan L, Tos APD, Trentin L, Vianello F.   +9 more
europepmc   +2 more sources

Cutaneous Focal Mucinosis Successfully Treated With Superpulsed Carbon Dioxide Laser. [PDF]

Case Rep Med
Cutaneous focal mucinosis (CFM) is a rare dermatological condition characterized by localized mucin deposition in the dermis, presenting as solitary or multiple asymptomatic papules or nodules. Treatment options are limited, with spontaneous resolution occurring in some cases, while others persist or require intervention.
Hekmat M, Hosseini A, Shirazi Yeganeh B, Fazelzadeh Haghighi N.   +3 more
europepmc   +2 more sources

Sclerosing diseases of the skin. [PDF]

J Dtsch Dermatol Ges
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Kalantari Y, Meier K, Ghoreschi K, Kinberger M, Solimani F.   +4 more
europepmc   +2 more sources

Discrete papular lichen myxedematosus successfully treated with isotretinoin [PDF]

JAAD Case Reports
Alexa Figueroa Baiges, BS, Nina Punyamurthy, MD, Alexander M. Maley, MD   +2 more
doaj   +2 more sources

Development and Validation of Algorithms for Systemic Sclerosis Identification in Electronic Health Record Data. [PDF]

ACR Open Rheumatol
Objective The aim of this study was to develop and validate International Classification of Diseases (ICD) code–based algorithms for identifying systemic sclerosis (SSc) cases within electronic health record (EHR) data and to evaluate algorithm performance. Methods We identified patients with at least one ICD, Ninth Revision (ICD‐9)/ICD‐10 code for SSc
Ozen G, O'Rorke M, Romitti P, Domsic R.
europepmc   +2 more sources